⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WHWK News
Whitehawk Therapeutics, Inc. Common Stock
Biocytogen y Whitehawk Therapeutics firman un acuerdo de colaboración internacional para el desarrollo de anticuerpos bispecíficos ADC
businesswire.com
WHWK
Biocytogen und Whitehawk Therapeutics vereinbaren weltweite Zusammenarbeit zur Entwicklung von bispezifischen Antikörper-Wirkstoff-Konjugaten (ADC)
businesswire.com
WHWK
Biocytogen und Whitehawk Therapeutics vereinbaren weltweite Zusammenarbeit zur Entwicklung von bispezifischen Antikörper-Wirkstoff-Konjugaten (ADC)
businesswire.com
WHWK
百奥赛图与Whitehawk Therapeutics达成全球合作，共同开发创新双特异性抗体ADC
businesswire.com
WHWK
百奥赛图与Whitehawk Therapeutics达成全球合作，共同开发创新双特异性抗体ADC
businesswire.com
WHWK
Form 8-K
sec.gov
WHWK
Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
prnewswire.com
WHWK
Form 8-K
sec.gov
WHWK
Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload
prnewswire.com
WHWK
Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit
prnewswire.com
WHWK